Psoralens in association with seasonal affective disorder

Medical Hypotheses

Volumn 50, Issue 6, 1998, Pages 481-482

  Partonen, T ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

MELATONIN; PSORALEN DERIVATIVE;

AFFECTIVE NEUROSIS; ARTICLE; DRUG EFFECT; DRUG MECHANISM; HORMONE BLOOD LEVEL; HUMAN; LIGHT EXPOSURE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0031799579     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-9877(98)90267-5     Document Type: Article

References (7)

1. Souetre E, Salvati E, Lacour J C et al. Psoralen and the suppression of melatonin secretion by bright light. Photochem Photobiol 1988; 47: 579-581.
2. Souêtre E, Salvati E, Belugou J-L, Krebs B, Darcourt G. 5-Methoxypsoralen increases evening sleepiness in humans: possible involvement of the melatonin secretion. Eur J Clin Pharmacol 1989; 36: 91-92.
3. Garde E, Micic S, Knudsen K, Angelo H R, Wulf H C. 8-Methoxypsoralen increases daytime plasma melatonin levels in humans through inhibition of metabolism. Photochem Photobiol 1994; 60: 475-480.
4. Thompson C, Stinson D, Smith A. Seasonal affective disorder and season-dependent abnormalities of melatonin suppression by light. Lancet 1990; 336: 703-706.
5. Saunas E O, Hakim-Kreis C M, Piketty M L, Dardennes R M, Musa C Z. Hypersecretion of melatonin following diurnal exposure to bright light in seasonal affective disorder: preliminary results. Biol Psychiatry 1992; 32: 387-398.
6. 3 in winter seasonal affective disorder. Biol Psychiatry 1996; 39: 865-872.
7. Danilenko K V, Putilov A A, Russkikh G S, Duffy L K, Ebbesson S O E. Diurnal and seasonal variations of melatonin and serotonin in women with seasonal affective disorder. Arct Med Res 1994; 53: 137-145.